The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
326
Episode 73: Canadian pills, corporate jets, & r...
Will Canada run out of drugs? Should you ever rea…
23 min
327
Episode 72: Vertex's regime change, the return ...
What makes an epidemic newsworthy? Can biotech su…
26 min
328
Episode 71: Elon Musk's monkey cyborg, Gilead's...
Can apps treat anxiety? Is Gilead Sciences back o…
25 min
329
Episode 70: A whirlwind week in Washington, Sea...
Is drug pricing too complex for the Trump adminis…
29 min
330
Episode 69: The future of AbbVieGan, the dogma ...
Can Botox make Big Pharma attractive? What qualif…
25 min
331
Episode 68: A controversial desire drug, courtr...
Is desire a matter of medicine? Can you convict o…
26 min
332
Episode 67: Biohacking meets bureaucracy, and t...
Is biohacking a crime? Who came up with the lates…
25 min
333
Episode 66: The future of cancer treatment, blo...
Who won ASCO? Is pharma sandbagging its blockbust…
26 min
334
Episode 65: A special episode from the halls of...
What can be done to improve HPV vaccination rates…
29 min
335
Episode 64: Feuding professors, failing busines...
Who's guilty of "clickbait"? Are spit tubes a bad…
23 min
336
Episode 63: Your ASCO preview, genetic whiplash...
What should you watch for at the year's biggest c…
31 min
337
Episode 62: Drug pricing partisanship, tech's m...
Has drug price reform already stalled? How far ha…
23 min
338
Episode 61: Pharma felonies, cardiac CRISPR, an...
Are law-breaking pharma executives the new mob bo…
25 min
339
Episode 60: Boardroom drama, whiskey-fueled sci...
Is Biogen bracing for a fight? What does Jack Dan…
22 min
340
Episode 59: When scientists get mad online, for...
Who gets to be "influential"? Should you be skept…
22 min
341
Episode 58: Democratizing CRISPR, drugging the ...
Who gets to "play God"? Can old technologies lear…
21 min
342
Episode 57: Trump’s drug pricing foot soldier, ...
How do you sell lefty ideas to righty politicians…
25 min
343
Episode 56: Cheaper insulin, the next Juul, and...
What if pharma just charged less for drugs? Can s…
28 min
344
Episode 55: The fate of Bristol-Myers-Celgene, ...
Why can't investors think for themselves? How do …
26 min
345
Episode 54: Another big Alzheimer’s failure, po...
Should Alzheimer's researchers just give up on am…
31 min
346
Episode 53: How startups stop, the new FDA boss...
Who deserves credit for a new gene therapy? How d…
31 min
347
Episode 52: Every conceivable angle of Scott Go...
Why is Scott Gottlieb quitting the FDA? Who will …
28 min
348
Episode 51: CEOs at the Senate, merger mania, a...
Is this the age of the big biotech buyout? Is col…
26 min
349
Episode 50: A big scoop on opioid marketing
What did an opioid patriarch say under oath? Why …
13 min
350
Episode 49: Painkiller racketeering, the limits...
Is pharma about to have its Big Tobacco moment? A…
23 min